Author: admin

Medical Devices-USA/Europe Regulatory News – April 2023

April 4, 2023
Medical Device

USA (FDA) Cybersecurity in Medical Devices: Refuse to Accept Policy for Cyber Devices and Related Systems Under Section 524B of the FD&C Act-Guidance for Industry and Food and Drug Administration...

Europe Regulatory News, FIMEA, HPRA, Medical Devices, MHRA, Regulatory News, Swissmedic, US FDA, USA Regulatory News

FDA Authority Over Cosmetics

March 24, 2023
Cosmetics

Cosmetics are constituted mixtures of chemical compounds derived from either natural sources, or synthetically created ones. Cosmetics have various purposes. Those designed for personal care and skin...

Cosmetic Labeling, Cosmetic Registration, FDA Cosmetics Regulations, Laws and Regulations, Product Safety

Pharma/Biotech – Asia, ROW Regulatory News, March 2023 Vol. 2

March 21, 2023
Biopharma

Pakistan Pakistan’s DRAP encourages users to update pharmacovigilance app after recent revisions The Drug Regulatory Authority of Pakistan (DRAP) has asked users of its Med Safety App to update...

Medical Devices – Asia and ROW Regulatory News – March 2023

March 21, 2023
Medical Device

JAPAN (PMDA) Medical safety measures related to pharmaceuticals and medical devices The Ministry of Health, Labor and Welfare is promoting various efforts to prevent medical accidents, but it...

Asia Regulatory News, Medical Devices, Regulatory News, ROW Regulatory News

Maximizing Success and Mitigating Risk: The Strategic Role of Pharma Regulatory Intelligence Database in the Pharmaceutical Industry

March 14, 2023
Biopharma

Regulatory intelligence refers to the process of gathering and analyzing information about the regulatory landscape, including laws, policies, and guidelines, that may affect a particular industry....

Drug Development, Mitigating Risk, Pharma Regulatory Intelligence, Regulatory Affairs, Regulatory Intelligence, Regulatory Intelligence Database

Pharma/Biotech – USA, Europe Regulatory News, March 2023 Vol. 1

March 7, 2023
Biopharma

US FDA Offers Advice on Macular Degeneration Drug Trials The FDA outlined drug trial options for developers of neovascular age-related macular degeneration drugs in a newly published draft guidance....

Biotech Regulatory News, EU Regulatory News, Pharma Regulatory News, Regulatory News, USA Regulatory News